Biology Newsfeed

[Report] IgG antibodies to dengue enhanced for FcγRIIIA binding determine disease severity

ScienceNOW - Fetched: January 26th, 2017, 3:00pm UTC

Dengue virus (DENV) infection in the presence of reactive, non-neutralizing immunoglobulin G (IgG) (RNNIg) is the greatest risk factor for dengue hemorrhagic fever (DHF) or dengue shock syndrome (DSS). Progression to DHF/DSS is attributed to antibody-dependent enhancement (ADE); however, because only a fraction of infections occurring in the presence of RNNIg advance to DHF/DSS, the presence of RNNIg alone cannot account for disease severity. We discovered that DHF/DSS patients respond to infection by producing IgGs with enhanced affinity for the activating Fc receptor FcγRIIIA due to afucosylated Fc glycans and IgG1 subclass. RNNIg enriched for afucosylated IgG1 triggered platelet reduction in vivo and was a significant risk factor for thrombocytopenia. Thus, therapeutics and vaccines restricting production of afucosylated, IgG1 RNNIg during infection may prevent ADE of DENV disease. Authors: Taia T. Wang, Jaturong Sewatanon, Matthew J. Memoli, Jens Wrammert, Stylianos Bournazos, Siddhartha Kumar Bhaumik, Benjamin A. Pinsky, Kulkanya Chokephaibulkit, Nattawat Onlamoon, Kovit Pattanapanyasat, Jeffery K. Taubenberger, Rafi Ahmed, Jeffrey V. Ravetch

Read more

Return to the Newsfeed